NRDL+ is a paid strategic intelligence service analysing China's health policy, insurance coverage and financing for pharmaceuticals and medical technologies. Its newsletter issues promote its mid-year and annual debriefs and interpret the 15th Five-Year medical security plan for manufacturers' access and pricing strategy.